Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive finan ...

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge,” published in the March ...

A Japanese study has found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics when their blood sugar levels drop, can potentially make diabetic ...

Chief executive Rodolphe Saadé has in recent years taken a significant portion of his quick-paced expansion spree to the U.S.

France-based CMA CGM, a major ocean shipping and logistics company, plans to spend $1 billion beefing up its cargo airline ...

President Donald Trump said shipping giant CMA CGM SA would invest $20 billion into the United States to build out shipping ...

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, AscensiaPatient ...

2-Year U.S. Treasury Note Continuous Contract $103.398 0.078 0.08% 5-Year U.S. Treasury Note Continuous Contract $107.813 0.211 0.20% 10-Year U.S. Treasury Note Continuous Contract $110.969 0.328 ...

Tandem Diabetes Care Inc. reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 ...